AI-assisted research summary: Dispensers must report controlled-substance and monitored-drug prescription information to the board, usually by the next business day, and the board sets reporting and records-retention rules.
§1006. Reporting of prescription monitoring information A. Each dispenser shall submit to the board information regarding each prescription dispensed for a controlled substance or drug monitored by the program. The information submitted for each prescription shall include, at a minimum, data relative to the identification of the following elements of the transaction: (1) Prescriber information. (2) Patient information. (3) Prescription information. (4) Controlled substance or drug information. (5) Dispenser information. B. Each dispenser shall submit the required information in accordance with transmission methods and frequency established by the board. Each eligible prescription transaction shall be reported no later than the next business day after the date of dispensing. C. The board may issue a waiver to a dispenser who is unable to submit prescription information by electronic means. The waiver shall state the format and frequency with which the dispenser shall submit the required information. The board may issue an exemption from the reporting requirement to a dispenser whose practice activities are inconsistent with the intent of the program. The board may rescind any previously issued exemption without the need for an informal or formal hearing. D. Any person or entity required to report information concerning prescriptions to the board or to its designated agent pursuant to the requirements of this Part shall not be liable to any person or entity for any claim of damages as a result of the act of reporting the information and no lawsuit may be predicated thereon. Any person or entity who submits report information in good faith containing prescription information that is not the subject of the PMP shall not be liable to any person or entity for any claim of damages and no lawsuit may be predicated thereon. E. The prescription monitoring program's agents, a dispenser, or a prescriber may report suspected violations of this Section or violations of any law to any local, state, out-of-state, or federal law enforcement agency, or the appropriate prosecutorial agency for further investigation or prosecution. F. No agent, dispenser, or prescriber who in good faith reports suspected violations as provided for in Subsection E of this Section shall be liable to any person or entity for any claim of damages as a result of the act of reporting the information, and no lawsuit may be predicated thereon. G. The board shall establish by rulemaking standards for the retention, archiving, and destruction of prescription monitoring information and audit trail information. Nothing in this Section shall be construed to modify or abrogate the provisions of R.S. 44:411. H. All agencies, as defined in R.S. 44:402, shall keep all records for the time specified in records retention schedules approved by the state archivist and director of the division archives, records management, and history of the Department of State and shall obtain the state archivist's approval before destroying any records in the agency's custody, pursuant to the provisions of R.S. 44:411. Acts 2006, No. 676, §1, eff. July 1, 2006; Acts 2009, No. 129, §1; Acts 2009, No. 314, §1; Acts 2010, No. 488, §1, eff. June 22, 2010; Acts 2014, No. 472, §1; Acts 2016, No. 189, §1; Acts 2018, No. 206, §4; Acts 2025, No. 159, §1.